MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
20.88
+0.39 (1.90%)
Jul 23, 2025, 1:15 PM - Market open
MediWound Stock Forecast
Stock Price Forecast
The 2 analysts that cover MediWound stock have a consensus rating of "Strong Buy" and an average price target of $35, which forecasts a 67.58% increase in the stock price over the next year. The lowest target is $31 and the highest is $39.
Price Target: $35 (+67.58%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 22, 2025.
Analyst Ratings
The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +48.47% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +19.73% | Mar 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +86.78% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +19.73% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +19.73% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
24.40M
from 20.22M
Increased by 20.64%
Revenue Next Year
30.67M
from 24.40M
Increased by 25.71%
EPS This Year
-2.13
from -3.03
EPS Next Year
-2.43
from -2.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.7M | 34.4M | 39.8M | ||
| Avg | 24.4M | 30.7M | 36.2M | ||
| Low | 23.0M | 25.9M | 32.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.0% | 40.9% | 29.8% | ||
| Avg | 20.6% | 25.7% | 18.2% | ||
| Low | 13.9% | 6.3% | 6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.35 | -1.68 | -1.41 | ||
| Avg | -2.13 | -2.43 | -2.08 | ||
| Low | -2.27 | -3.14 | -2.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.